REDYPHEND Trademark

Trademark Overview

On Monday, April 18, 2016, a trademark application was filed for REDYPHEND with the United States Patent and Trademark Office. The USPTO has given the REDYPHEND trademark a serial number of 87004337. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2020. This trademark is owned by EUROHEALTH INTERNATIONAL SARL. The REDYPHEND trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, injectable phenylephrine hydrochloride intended for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation, in such settings as septic shock or anesthesia
redyphend

General Information

Serial Number87004337
Word MarkREDYPHEND
Filing DateMonday, April 18, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 13, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 18, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, injectable phenylephrine hydrochloride intended for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation, in such settings as septic shock or anesthesia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 21, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEUROHEALTH INTERNATIONAL SARL
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGeneve 1205
CH
Party NameEUROHEALTH INTERNATIONAL SARL
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Address1205 Geneve
CH

Trademark Events

Event DateEvent Description
Monday, January 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 13, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 1, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 31, 2019EXTENSION 5 GRANTED
Tuesday, May 28, 2019EXTENSION 5 FILED
Friday, May 31, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 28, 2019TEAS EXTENSION RECEIVED
Friday, November 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 28, 2018EXTENSION 4 GRANTED
Wednesday, November 28, 2018EXTENSION 4 FILED
Wednesday, November 28, 2018TEAS EXTENSION RECEIVED
Saturday, March 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 8, 2018EXTENSION 3 GRANTED
Thursday, March 8, 2018EXTENSION 3 FILED
Thursday, March 8, 2018TEAS EXTENSION RECEIVED
Saturday, November 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 2, 2017EXTENSION 2 GRANTED
Thursday, November 2, 2017EXTENSION 2 FILED
Thursday, November 2, 2017TEAS EXTENSION RECEIVED
Thursday, May 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 23, 2017EXTENSION 1 GRANTED
Tuesday, May 23, 2017EXTENSION 1 FILED
Tuesday, May 23, 2017TEAS EXTENSION RECEIVED
Tuesday, December 13, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 18, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 18, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 28, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 27, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 26, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 13, 2016NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, July 13, 2016PRIORITY ACTION E-MAILED
Wednesday, July 13, 2016PRIORITY ACTION WRITTEN
Wednesday, July 13, 2016ASSIGNED TO EXAMINER
Thursday, April 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 21, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

redyphend from primarily resulting hypotension vasodilation such anesthesia shock septic settings